Abstract
SAR studies at the N(1)-position of allosteric indole-based HCV NS5B inhibitors has led to the discovery of acetamide derivatives with good cellular potency in subgenomic replicons (EC(50) <200 nM). This class of inhibitors displayed improved physicochemical properties and favorable ADME-PK profiles over previously described analogs in this class.
Copyright (c) 2010 Elsevier Ltd. All rights reserved.
MeSH terms
-
Acetamides / chemistry*
-
Acetamides / pharmacology
-
Allosteric Regulation / drug effects
-
Allosteric Regulation / physiology
-
Antiviral Agents / chemical synthesis*
-
Antiviral Agents / pharmacology
-
Caco-2 Cells
-
Carboxylic Acids / chemistry*
-
Carboxylic Acids / pharmacology
-
Cell Line
-
DNA-Directed RNA Polymerases / antagonists & inhibitors
-
DNA-Directed RNA Polymerases / metabolism
-
Drug Discovery* / methods
-
Hepacivirus / drug effects
-
Hepacivirus / enzymology*
-
Humans
-
Microsomes, Liver / enzymology
-
RNA-Dependent RNA Polymerase / antagonists & inhibitors*
-
RNA-Dependent RNA Polymerase / metabolism
-
Viral Nonstructural Proteins / antagonists & inhibitors*
-
Viral Nonstructural Proteins / metabolism
Substances
-
Acetamides
-
Antiviral Agents
-
Carboxylic Acids
-
Viral Nonstructural Proteins
-
NS-5 protein, hepatitis C virus
-
RNA-Dependent RNA Polymerase
-
DNA-Directed RNA Polymerases